These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 5327174)

  • 1. [Current trends in the prevention and therapy of hemolytic disease in the fetus and newborn infant. Review note].
    Marsico S
    Arch Ostet Ginecol; 1965; 70(6):508-30. PubMed ID: 5327174
    [No Abstract]   [Full Text] [Related]  

  • 2. [Therapy and prevention of hemolytic disease of the newborn].
    COUTINHO H
    Gaz Med Port; 1952; 5(3):401-14. PubMed ID: 12980260
    [No Abstract]   [Full Text] [Related]  

  • 3. Diagnosis, prevention, and therapy in hemolytic disease of the newborn.
    Polesky HF
    Clin Lab Med; 1982 Mar; 2(1):107-22. PubMed ID: 6821161
    [No Abstract]   [Full Text] [Related]  

  • 4. [New trends in the prevention and treatment of hemolytic disease in the newborn with Rh incompatibility].
    Ilieva V
    Akush Ginekol (Sofiia); 1967; 6(5):423-33. PubMed ID: 5601012
    [No Abstract]   [Full Text] [Related]  

  • 5. [Prevention and treatment of hemolytic disease of the newborn in secondary hospitals].
    Cadorini S
    Riv Clin Pediatr; 1968; 81(6):1186-9. PubMed ID: 5761269
    [No Abstract]   [Full Text] [Related]  

  • 6. [The Kleihauer test and directed prevention of hemolytic disease of the newborn due to materno-fetal Rh-factor isoimmunization. Preventive note].
    De Luca P; Adinolfi G; Corbo M
    Minerva Ginecol; 1980 Dec; 32(12):1179-81. PubMed ID: 6793940
    [No Abstract]   [Full Text] [Related]  

  • 7. [The importance of unusual isoimmunizations in the prophylaxis of hemolytic disease of the newborn].
    Joó-Szabados T; Neubauer G; Székessy V; Wohlmuth G
    Acta Paediatr Acad Sci Hung; 1970; 11(2):111-4. PubMed ID: 5504582
    [No Abstract]   [Full Text] [Related]  

  • 8. [Activity of the Center for study of Rh factors of the Clinica Ostetrica e Ginecologica of the University of Naples in the prevention of hemolytic disease of the newborn].
    Paladini A; Di Martino D; De Luca P; Rascio B; Di Lieto A
    Arch Ostet Ginecol; 1969 Dec; 74(6):461-75. PubMed ID: 5406384
    [No Abstract]   [Full Text] [Related]  

  • 9. [Prevention of hemolytic disease of the fetus and the newborn: it is necessary to act].
    Mannessier L; Alie-Daram S; Roubinet F; Valat AS; Depoortère MH; Fournié A; Puech F
    J Gynecol Obstet Biol Reprod (Paris); 2000 Sep; 29(5):441-4. PubMed ID: 11011272
    [No Abstract]   [Full Text] [Related]  

  • 10. Noninvasive approaches to the management of RhD hemolytic disease of the fetus and newborn.
    Urbaniak SJ
    Transfusion; 2008 Jan; 48(1):2-5. PubMed ID: 18184231
    [No Abstract]   [Full Text] [Related]  

  • 11. [On the passage of fetal erythrocytes into the maternal circulation and prevention of perinatal hemolytic disease].
    Botella Llusiá J
    An R Acad Nac Med (Madr); 1966; 83(2):159-67. PubMed ID: 5952983
    [No Abstract]   [Full Text] [Related]  

  • 12. [A new therapeutic possibility in Rh-isoimmune hemolytic disease of the newborn. The use of Rh-positive blood based on the study of free anti-D antibody in the newborn infant. (Preliminary note)].
    Pataki L; Kaiser G; Virág I; Román F
    Orv Hetil; 1967 Feb; 108(8):352-4. PubMed ID: 6041608
    [No Abstract]   [Full Text] [Related]  

  • 13. [Immunologically induced hemolytic anemias].
    Hitzig WH; Lo SS
    Ther Umsch; 1968 Aug; 25(8):426-32. PubMed ID: 5729306
    [No Abstract]   [Full Text] [Related]  

  • 14. [Hemolytic disease of the newborn: prospects of diagnosis, prevention and therapy].
    Di Toro R
    Pediatria (Napoli); 1968 Dec; 76(6):833-44. PubMed ID: 5754147
    [No Abstract]   [Full Text] [Related]  

  • 15. [Contribution of spectrophotometry of amniotic fluid to the prevention of hemolytic disease of the newborn].
    Zwinger A; Vedra B; Polácek K
    Cesk Gynekol; 1969 Oct; 34(8):478-81. PubMed ID: 5354331
    [No Abstract]   [Full Text] [Related]  

  • 16. [The prevention of the Rh hemolytic disease of the newborn].
    Baumgarten K; Reinold E
    Wien Med Wochenschr; 1970 May; 120(18):319-20. PubMed ID: 5490864
    [No Abstract]   [Full Text] [Related]  

  • 17. Rh immunoglobulin in prevention of hemolytic disease of newborn child.
    Gorman JG
    N Y State J Med; 1983 Jan; 83(1):42-9. PubMed ID: 6402737
    [No Abstract]   [Full Text] [Related]  

  • 18. [Rare isoimmunizations and the prevention of hemolytic disease in the newborn].
    Joó-Szabados T; Neubauer G; Székessy V; Wohlmuth G
    Orv Hetil; 1970 Sep; 111(36):2112-3. PubMed ID: 5470606
    [No Abstract]   [Full Text] [Related]  

  • 19. [A case of hemolytic disease of the newborn caused by materno-fetal isoimmunization against factor c(hr') (preliminary note)].
    De Luca P
    Arch Ostet Ginecol; 1980; 85(3):175-7. PubMed ID: 6802114
    [No Abstract]   [Full Text] [Related]  

  • 20. [Intensive plasma exchange for the prevention of hemolytic disease of the newborn caused by anti-Rhesus alloimmunization].
    Dupont E; Lambermont M; Thayse C; Gammar N; Vanherweghem JL; Rodesh F; Schwers J; Wybran J
    Rev Med Brux; 1983 Dec; 4(10):663-6. PubMed ID: 6658250
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.